Immunotherapy With Rituximab (RITUXAN)/Interleukin 2 (IL-2) Following Autologous Peripheral Blood Stem Cell Transplant (ASCT) as Treatment for CD20 Positive Non-Hodgkin's Lymphoma

✍ Scribed by L.A. Holmberg; D.G. Maloney; W.I. Bensinger

• Book ID: 116280630
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 49 KB
• Volume: 15
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2008.12.117